Azacitidine (Actavis Pharma, Inc.)
Welcome to the PulseAid listing for the Azacitidine drug offered from Actavis Pharma, Inc.. This Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Actavis Pharma, Inc. |
NON-PROPRIETARY NAME: | Azacitidine |
SUBSTANCE NAME: | AZACITIDINE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
ROUTE: | INTRAVENOUS; SUBCUTANEOUS |
DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2016-09-22 |
END MARKETING DATE: | 0000-00-00 |
Azacitidine HUMAN PRESCRIPTION DRUG Details:
Item Description | Azacitidine from Actavis Pharma, Inc. |
LABELER NAME: | Actavis Pharma, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 100(mg/1) |
START MARKETING DATE: | 2016-09-22 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0591-2897_ba887c6a-ff20-4683-b210-c673928060b8 |
PRODUCT NDC: | 0591-2897 |
APPLICATION NUMBER: | NDA208216 |
Other AZACITIDINE Pharmaceutical Manufacturers / Labelers: